Sumatriptan Tablet, Film Coated
NDC Package 53873-059-00

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Sumatriptan tablets is sumatriptan is used to treat migraines. This formulation utilizes a tablet, film coated delivery system. Marketed by Bora Pharmaceutical Services Inc., this product is identified by NDC 53873-059.

Identification & Billing

NDC Package Code
53873-059-00
Package Description
60000 TABLET, FILM COATED in 1 DRUM
Product Code
53873-059
11-Digit Billing Format
53873005900

Clinical Specifications

Proprietary Name
Sumatriptan
Non-Proprietary Name
Sumatriptan
Substance Name
Sumatriptan Succinate
Dosage Form
Tablet, Film Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer.
Active Ingredient(s)
SUMATRIPTAN SUCCINATE 100 mg/1
Usage Information
Sumatriptan is used to treat migraines. It helps to relieve headache, pain, and other migraine symptoms (including nausea, vomiting, sensitivity to light/sound). Prompt treatment helps you return to your normal routine and may decrease your need for other pain medications. Sumatriptan belongs to a class of drugs known as triptans. It affects a certain natural substance (serotonin) that causes narrowing of blood vessels in the brain. It may also relieve pain by affecting certain nerves in the brain. Sumatriptan does not prevent future migraines or lessen how often you get migraine attacks.

Regulatory & Marketing

Labeler Name
Bora Pharmaceutical Services Inc.
Product Type
Drug For Further Processing
Marketing Category
DRUG FOR FURTHER PROCESSING - A drug (other than the bulk ingredient API) that is in an interim stage of manufacture, processing, preparation, or packaging, and not ready for human or animal use.
Start Marketing Date
12-19-2003
Listing Expiration
12-31-2026
Exclude Flag
N
Unfinished Product
Yes
Sample Package
N/A

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 53873-059-00 identifies a specific commercial package of 60000 tablet, film coated in 1 drum of Sumatriptan (UNFINISHED drug), drug for further processing labeled by Bora Pharmaceutical Services Inc.. This tablet, film coated is formulated for use and contains sumatriptan succinate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Bora Pharmaceutical Services Inc. on December 19, 2003. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

Sumatriptan is used to treat migraines. It helps to relieve headache, pain, and other migraine symptoms (including nausea, vomiting, sensitivity to light/sound). Prompt treatment helps you return to your normal routine and may decrease your need for other pain medications. Sumatriptan belongs to a class of drugs known as triptans. It affects a certain natural substance (serotonin) that causes narrowing of blood vessels in the brain. It may also relieve pain by affecting certain nerves in the brain. Sumatriptan does not prevent future migraines or lessen how often you get migraine attacks.

How is this Bora Pharmaceutical Services Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 53873005900. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
53873-059-00
11-Digit CMS (5-4-2)
53873-0059-00

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.